Uwe Platzbecker, MD
Universitätsklinikum Leipzig · Universität Leipzig · Medizinische Klinik I, Universitätsklinikum Carl-Gustav-Carus, Dresden, Germany
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Uwe Platzbecker, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:25 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05583552 · Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based TherapyGCP-Service International West GmbH · completed · Myelodysplastic Syndromes, Acute Myeloid Leukemia · principal investigator
- N/ANCT02867085 · Study Investigating the Interactions of Bone and Hematopoiesis in the ElderlyTechnische Universität Dresden · completed · Myelodysplastic Syndromes · principal investigator
- Ph2NCT01111448 · Temsirolimus in Myelodysplastic Syndrome (MDS)Technische Universität Dresden · terminated · Myelodysplastic Syndrome · principal investigator
- Ph1NCT00923234 · Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic SyndromesTechnische Universität Dresden · terminated · Myelodysplastic Syndromes, Acute Myelogenous Leukemia · principal investigator
- Ph3NCT00422890 · Treatment of Imminent Haematological Relapse in Patients With AML and MDS Following Allogeneic Stem Cell Transplantation With 5-azacitidine (Vidaza®)Technische Universität Dresden · completed · Myeloid Leukemia, Myelodysplastic Syndrome · principal investigator
- Ph2/Ph3NCT00117702 · Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and EverolimusTechnische Universität Dresden · terminated · Graft vs Host Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.